| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Journal of Clinical Endocrinology & Metabolism, Vol 79, 1806-1810, Copyright © 1994 by Endocrine Society
ARTICLES |
SM Haffner, L Mykkanen, RA Valdez, MP Stern, DL Holloway, A Monterrosa and RR Bowsher
Department of Medicine, University of Texas Health Science Center, San Antonio 78284.
Recent data suggest that proinsulin may be associated with increased cardiovascular risk factors in both diabetic and nondiabetic subjects. We examined the relation of insulin, proinsulin, and the fasting proinsulin/insulin ratio to a number of metabolic disorders believed to be related to the insulin resistance syndrome (low high density lipoprotein cholesterol and high triglyceride levels, hypertension, and impaired glucose tolerance). Proinsulin was measured by a RIA, and insulin was measured by a Linco RIA that does not cross-react with proinsulin. The increased fasting proinsulin/insulin ratio was significantly associated with hypertension, low high density lipoprotein cholesterol and high triglyceride levels, and impaired glucose tolerance in 423 nondiabetic subjects. The fasting proinsulin/insulin ratio increased significantly with the number of metabolic disorders (zero, 0.060; one, 0.086; two, 0.098; three, 0.177; four, 0.182; P < 0.001). The increased proinsulin/insulin ratio was also associated with a greater number of metabolic disorders in diabetic subjects. Our results show that particularly nondiabetic individuals with the insulin resistance syndrome not only have hyperinsulinemia as a marker of insulin resistance, but also show an increase in proinsulin relative to insulin, which may reflect relative beta-cell failure or malfunction.
This article has been cited by other articles:
![]() |
R. Sapin Insulin Immunoassays: Fast Approaching 50 Years of Existence and Still Calling for Standardization Clin. Chem., May 1, 2007; 53(5): 810 - 812. [Full Text] [PDF] |
||||
![]() |
S. Marcovina, R. R. Bowsher, W. G. Miller, M. Staten, G. Myers, S. P. Caudill, S. E. Campbell, M. W. Steffes, and for the Insulin Standardization Workgroup Standardization of Insulin Immunoassays: Report of the American Diabetes Association Workgroup Clin. Chem., April 1, 2007; 53(4): 711 - 716. [Abstract] [Full Text] [PDF] |
||||
![]() |
D.-J. Kim and E. Barrett-Connor Association of serum proinsulin with hormone replacement therapy in nondiabetic older women: the rancho bernardo study. Diabetes Care, March 1, 2006; 29(3): 618 - 624. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Alssema, J. M. Dekker, G. Nijpels, C. D.A. Stehouwer, L. M. Bouter, and R. J. Heine Proinsulin Concentration Is an Independent Predictor of All-Cause and Cardiovascular Mortality: An 11-year follow-up of the Hoorn Study Diabetes Care, April 1, 2005; 28(4): 860 - 865. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Zethelius, C. N. Hales, H. O. Lithell, and C. Berne Insulin Resistance, Impaired Early Insulin Response, and Insulin Propeptides as Predictors of the Development of Type 2 Diabetes: A population-based, 7-year follow-up study in 70-year-old men Diabetes Care, June 1, 2004; 27(6): 1433 - 1438. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Maliqueo, I. Atwater, R. Lahsen, F. Perez-Bravo, B. Angel, and T. Sir-Petermann Proinsulin serum concentrations in women with polycystic ovary syndrome: a marker of {beta}-cell dysfunction? Hum. Reprod., December 1, 2003; 18(12): 2683 - 2688. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Chin, S. E. Oberfield, M. E. Silfen, D. J. McMahon, A. M. Manibo, D. Accili, and L. S. Levine Proinsulin in Girls: Relationship to Obesity, Hyperinsulinemia, and Puberty J. Clin. Endocrinol. Metab., October 1, 2002; 87(10): 4673 - 4677. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Haffner and A. J.G. Hanley Do Increased Proinsulin Concentrations Explain the Excess Risk of Coronary Heart Disease in Diabetic and Prediabetic Subjects? Circulation, April 30, 2002; 105(17): 2008 - 2009. [Full Text] [PDF] |
||||
![]() |
J.-Y. Oh, E. Barrett-Connor, and N. M. Wedick Sex Differences in the Association Between Proinsulin and Intact Insulin With Coronary Heart Disease in Nondiabetic Older Adults: The Rancho Bernardo Study Circulation, March 19, 2002; 105(11): 1311 - 1316. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Bokemark, J. Wikstrand, and B. Fagerberg Intact Insulin, Insulin Propeptides, and Intima-media Thickness in the Femoral Artery in 58-year-old Clinically Healthy Men: The Atherosclerosis and Insulin Resistance Study Angiology, April 1, 2001; 52(4): 237 - 245. [Abstract] [PDF] |
||||
![]() |
U. Lindblad, R. D. Langer, D. L. Wingard, R. G. Thomas, and E. L. Barrett-Connor Metabolic Syndrome and Ischemic Heart Disease in Elderly Men and Women Am. J. Epidemiol., March 1, 2001; 153(5): 481 - 489. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Lindahl, B. Dinesen, M. Eliasson, M. Roder, G. Hallmans, and B. Stegmayr High Proinsulin Levels Precede First-Ever Stroke in a Nondiabetic Population Stroke, December 1, 2000; 31(12): 2936 - 2941. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Røder, R. S. Schwartz, R. L. Prigeon, and S. E. Kahn Reduced Pancreatic B Cell Compensation to the Insulin Resistance of Aging: Impact on Proinsulin and Insulin Levels J. Clin. Endocrinol. Metab., June 1, 2000; 85(6): 2275 - 2280. [Abstract] [Full Text] |
||||
![]() |
J. B. Meigs, M. A. Mittleman, D. M. Nathan, G. H. Tofler, D. E. Singer, P. M. Murphy-Sheehy, I. Lipinska, R. B. D'Agostino, and P. W. F. Wilson Hyperinsulinemia, Hyperglycemia, and Impaired Hemostasis: The Framingham Offspring Study JAMA, January 12, 2000; 283(2): 221 - 228. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Larsson and B. Ahrén Relative Hyperproinsulinemia as a Sign of Islet Dysfunction in Women with Impaired Glucose Tolerance J. Clin. Endocrinol. Metab., June 1, 1999; 84(6): 2068 - 2074. [Abstract] [Full Text] |
||||
![]() |
S. M. Haffner The Importance of Hyperglycemia in the Nonfasting State to the Development of Cardiovascular Disease Endocr. Rev., October 1, 1998; 19(5): 583 - 592. [Abstract] [Full Text] |
||||
![]() |
S. M. Haffner, R. D'Agostino Jr, L. Mykkanen, C. N. Hales, P. J. Savage, R. N. Bergman, D. O'Leary, M. Rewers, J. Selby, R. Tracy, et al. Proinsulin and Insulin Concentrations in Relation to Carotid Wall Thickness : Insulin Resistance Atherosclerosis Study Stroke, August 1, 1998; 29(8): 1498 - 1503. [Abstract] [Full Text] [PDF] |
||||
![]() |
P.-W. Wang, F. Abbasi, M. Carantoni, Y.-D. I. Chen, S. Azhar, and G. M. Reaven Insulin Resistance Does Not Change the Ratio of Proinsulin to Insulin in Normal Volunteers J. Clin. Endocrinol. Metab., October 1, 1997; 82(10): 3221 - 3224. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Zethelius, L. Byberg, C. N. Hales, H. Lithell, and C. Berne Proinsulin Is an Independent Predictor of Coronary Heart Disease: Report From a 27-Year Follow-Up Study Circulation, May 7, 2002; 105(18): 2153 - 2158. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |